Updated Guidance Suggests that Federal Government May Enforce Contractor Vaccine Mandate
Client Alert | 1 min read | 10.18.22
The Safer Federal Workforce Task Force issued updated guidance for federal contractors on October 14, 2022, announcing that it will reevaluate enforcement of the federal contractor vaccine mandate and safety requirements issued under Executive Order 14042. This is the first pronouncement from the Task Force after it had indicated that it would not enforce the vaccine mandate without further notice in the wake of the Eleventh Circuit’s August 26, 2022 decision limiting the scope of the injunction against implementation and enforcement of the EO 14042 contractor mandate. The mandate officially narrowing the injunction was issued on October 18.
In light of the narrowed injunction, the Task Force announced that it will not enforce the vaccine mandate unless and until (i) the Task Force issues new guidance on COVID-19 safety protocols, (ii) OMB determines that guidance would promote economic and efficiency in federal contracting, and (iii) agencies issue written notice to covered contractors in accordance with OMB guidelines. The Task Force update leaves open the possibility that agencies could include the FAR clause implementing the requirements of the Executive Order in future solicitations and contracts.
In light of this announcement, federal contractors should expect that the Federal Government will not take any action to enforce the clause implementing the EO 14042 contractor mandate where it has already been included in contracts or contract-like instruments, absent further written notice from the agency.
Contacts
Insights
Client Alert | 3 min read | 01.21.26
Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement
On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion.
Client Alert | 3 min read | 01.21.26
FedRAMP Proposes Updates to Authorization Process—Six New RFCs Released for Public Comment
Client Alert | 3 min read | 01.20.26
DoW Joins SBA’s Fight Against Alleged Pass-Through Fraud in the 8(a) Program
Client Alert | 3 min read | 01.20.26
Federal Government Challenges Minnesota Law Requiring Affirmative Action in State Government




